Hiddo J.L. Heerspink
- Dapagliflozin in Patients with Chronic Kidney Disease
2020/09/24 by Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter +11 · 65 citations
Medicine · #Chronic Kidney Disease and Diabetes #Diabetes Treatment and Management #Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
2019/04/17 by Hiddo J.L. Heerspink, Hiddo J. L. Heerspink, Paul Perco +5 · 32 citations
Medicine · #Diabetes Treatment and Management #Pancreatic function and diabetes #Chronic Kidney Disease and Diabetes
- First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria
2008/12/18 by Elsbeth C. Witte, Hiddo J.L. Heerspink, Hiddo J. Lambers Heerspink +6 · 1 citation
Medicine · #Blood Pressure and Hypertension Studies #Chronic Kidney Disease and Diabetes #Renal and Vascular Pathologies
- Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
2024/08/30 by Brendon L. Neuen, Robert A. Fletcher, Lauren Heath +8 · 1 voice · 3 citations
Medicine · #Diabetes Treatment and Management #Heart Failure Treatment and Management #Pancreatic function and diabetes
- Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application
2024/09/26 by Erik Moedt, Victor Wasehuus, Hiddo J.L. Heerspink · 1 voice · 1 citation
Medicine · Neuroscience · #Blood Pressure and Hypertension Studies #Neurological Disorders and Treatments #Nitric Oxide and Endothelin Effects
- COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics
2025/01/29 by Rajiv Agarwal, Jennifer B. Green, Hiddo J.L. Heerspink +96 · 1 voice · 1 citation
Medicine · #Hormonal Regulation and Hypertension #Diabetes Treatment and Management #Parathyroid Disorders and Treatments